Full Year 2023 Inventiva SA Earnings Call Transcript
©© -
Thank you. Good morning and good afternoon, everybody, and thanks for joining us today for this webcast. Before we begin, as usual, ask you to please read the disclaimer on slide 2 which should appear now, and I want to remind everyone that various statements that we may make during today's conference or during the Q&A session will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Today in this call, I am joined by Joe measurability, our CFO, and by our CFO and Co-Founder of Carebook.
So let me go back to some of the highlights of many people in our development program by starting by 83. So in January '23, we announced some important changes to the design of the Phase three evaluating learning in patients with NASH NASH, which made us to be more attractive for the site and especially more patient friendly. This new design is based on discussion we had with the FDA on the alternative approach put forward by the U.S. FDA, which includes two
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
